15-90231027-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006384.4(CIB1):​c.466-5C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.268 in 1,613,294 control chromosomes in the GnomAD database, including 66,588 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6162 hom., cov: 32)
Exomes 𝑓: 0.27 ( 60426 hom. )

Consequence

CIB1
NM_006384.4 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.002671
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.323
Variant links:
Genes affected
CIB1 (HGNC:16920): (calcium and integrin binding 1) This gene encodes a member of the EF-hand domain-containing calcium-binding superfamily. The encoded protein interacts with many other proteins, including the platelet integrin alpha-IIb-beta-3, DNA-dependent protein kinase, presenilin-2, focal adhesion kinase, p21 activated kinase, and protein kinase D. The encoded protein may be involved in cell survival and proliferation, and is associated with several disease states including cancer and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 15-90231027-G-C is Benign according to our data. Variant chr15-90231027-G-C is described in ClinVar as [Benign]. Clinvar id is 1167687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.675 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CIB1NM_006384.4 linkuse as main transcriptc.466-5C>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000328649.11 NP_006375.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CIB1ENST00000328649.11 linkuse as main transcriptc.466-5C>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_006384.4 ENSP00000333873 P1Q99828-1

Frequencies

GnomAD3 genomes
AF:
0.262
AC:
39822
AN:
152036
Hom.:
6154
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.188
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.398
Gnomad ASJ
AF:
0.180
Gnomad EAS
AF:
0.693
Gnomad SAS
AF:
0.449
Gnomad FIN
AF:
0.272
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.234
Gnomad OTH
AF:
0.274
GnomAD3 exomes
AF:
0.336
AC:
84388
AN:
251272
Hom.:
17495
AF XY:
0.332
AC XY:
45152
AN XY:
135826
show subpopulations
Gnomad AFR exome
AF:
0.188
Gnomad AMR exome
AF:
0.525
Gnomad ASJ exome
AF:
0.193
Gnomad EAS exome
AF:
0.707
Gnomad SAS exome
AF:
0.445
Gnomad FIN exome
AF:
0.276
Gnomad NFE exome
AF:
0.236
Gnomad OTH exome
AF:
0.288
GnomAD4 exome
AF:
0.269
AC:
392589
AN:
1461140
Hom.:
60426
Cov.:
34
AF XY:
0.273
AC XY:
198261
AN XY:
726904
show subpopulations
Gnomad4 AFR exome
AF:
0.181
Gnomad4 AMR exome
AF:
0.510
Gnomad4 ASJ exome
AF:
0.191
Gnomad4 EAS exome
AF:
0.666
Gnomad4 SAS exome
AF:
0.439
Gnomad4 FIN exome
AF:
0.277
Gnomad4 NFE exome
AF:
0.236
Gnomad4 OTH exome
AF:
0.274
GnomAD4 genome
AF:
0.262
AC:
39844
AN:
152154
Hom.:
6162
Cov.:
32
AF XY:
0.273
AC XY:
20332
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.188
Gnomad4 AMR
AF:
0.399
Gnomad4 ASJ
AF:
0.180
Gnomad4 EAS
AF:
0.694
Gnomad4 SAS
AF:
0.449
Gnomad4 FIN
AF:
0.272
Gnomad4 NFE
AF:
0.234
Gnomad4 OTH
AF:
0.273
Alfa
AF:
0.234
Hom.:
1433
Bravo
AF:
0.266
Asia WGS
AF:
0.515
AC:
1789
AN:
3478
EpiCase
AF:
0.224
EpiControl
AF:
0.228

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 64% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. -
CIB1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 18, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
8.6
DANN
Benign
0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0027
dbscSNV1_RF
Benign
0.054
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1044813; hg19: chr15-90774259; COSMIC: COSV60173766; COSMIC: COSV60173766; API